Literature DB >> 18560965

Effects and risks of radiofrequency ablation on the pulmonary tissue and vascular system: a preliminary histological study.

Eiji Ogawa1, Tatsuo Fukuse, Yoshinobu Toda, Hirokazu Kotani, Hiromi Wada, Toshiaki Manabe.   

Abstract

PURPOSE: Radiofrequency ablation (RFA) is one of the minimally invasive therapeutic modalities for malignant tumors. However, the effects and risks associated with RFA on pulmonary tumors have not yet been well investigated. We pathologically examined the effects of RFA on the healthy pulmonary parenchyma in the inflated and deflated states of swine lungs.
METHODS: We used two 2-year-old female pigs. Under general anesthesia, RFA was performed twice.
RESULTS: The mean duration of cauterization for the inflated lungs (93.0 +/- 65.4 s) was significantly shorter than that for the deflated lungs (390.3 +/- 75.6 seconds) (P = 0.0062). Histologically, the dilatation and congestion of the microvessels were more marked in the lungs. However, no histopathological differences were noticed between the inflated and deflated lungs. Adventitial degeneration was seen in the small vessels, but not in the wall of the large vessels.
CONCLUSIONS: This study confirmed, pathologically, that RFA is effective with an acceptable degree of minimal damage to the normal lung tissue, irrespective of its conditions, i.e., inflated or deflated, and can be safely done near the pulmonary vessels. Therefore, RFA appears to be a promising therapeutic strategy to control local lesions in the field of thoracic surgery.

Entities:  

Mesh:

Year:  2008        PMID: 18560965     DOI: 10.1007/s00595-007-3655-9

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  11 in total

Review 1.  Radiofrequency ablation of the liver: current status.

Authors:  J P McGhana; G D Dodd
Journal:  AJR Am J Roentgenol       Date:  2001-01       Impact factor: 3.959

2.  Percutaneous radiofrequency ablation of malignancies in the lung.

Authors:  D E Dupuy; R J Zagoria; W Akerley; W W Mayo-Smith; P V Kavanagh; H Safran
Journal:  AJR Am J Roentgenol       Date:  2000-01       Impact factor: 3.959

Review 3.  Image-guided radiofrequency tumor ablation: challenges and opportunities--part I.

Authors:  S Nahum Goldberg; D E Dupuy
Journal:  J Vasc Interv Radiol       Date:  2001-09       Impact factor: 3.464

4.  Massive hemorrhage during radiofrequency ablation of a pulmonary neoplasm.

Authors:  Cynthia Vaughn; George Mychaskiw; Patrick Sewell
Journal:  Anesth Analg       Date:  2002-05       Impact factor: 5.108

Review 5.  Image-guided radiofrequency tumor ablation: challenges and opportunities--part II.

Authors:  D E Dupuy; S N Goldberg
Journal:  J Vasc Interv Radiol       Date:  2001-10       Impact factor: 3.464

6.  Cerebral microembolization during radiofrequency ablation of lung malignancies.

Authors:  Steven C Rose; Mehran Fotoohi; David L Levin; James H Harrell
Journal:  J Vasc Interv Radiol       Date:  2002-10       Impact factor: 3.464

7.  A new radiofrequency thermal balloon catheter for pulmonary vein isolation.

Authors:  K Tanaka; S Satake; S Saito; S Takahashi; Y Hiroe; Y Miyashita; S Tanaka; M Tanaka; Y Watanabe
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

8.  Inhibition of Lewis lung carcinoma in mice by local microwave hyperthermia combined with immunomodulating Propionibacterium granulosum KP-45.

Authors:  S Szmigielski; S Zaboklicki; J Gil; J Jeljaszewicz; G Pulverer
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

9.  Percutaneous radiofrequency thermal ablation of lung VX2 tumors in a rabbit model using a cooled tip-electrode: feasibility, safety, and effectiveness.

Authors:  Jeong Min Lee; Gong Yong Jin; Chun Ai Li; Gyung Ho Chung; Sang Yong Lee; Young Min Han; Myoung Ja Chung; Chong Soo Kim
Journal:  Invest Radiol       Date:  2003-02       Impact factor: 6.016

10.  Percutaneous radiofrequency ablation of lung tumors in a large animal model.

Authors:  Kamran Ahrar; Roger E Price; Michael J Wallace; David C Madoff; Sanjay Gupta; Frank A Morello; Kenneth C Wright
Journal:  J Vasc Interv Radiol       Date:  2003-08       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.